Analysis and discussion of generic drug consistency evaluation in NMPA and relevant drug policies in FDA and PMDA
LI Dong
DU Hong-jin
ZHOU Yu
LIU Dong
LIU Yi-lin
HA Li-li
LI Fang
YANG Jin-bo
Machine-generated Keywords：
Publication Date：2021-07-15
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)
Pages：4( 1164-1167 )